Business · 17/05/1999Updated: 10/17/2026 · 1 min read
FDA Issues Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring
Summary
The FDA is issuing new regulations to clarify the evaluation and approval process for in vivo radiopharmaceuticals used in disease diagnosis and monitoring, in accordance with the Food and Drug Administration Modernization Act of 1997.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →